Priming of the neutrophil respiratory burst: role in host defense and inflammation

Immunological Reviews

Volumn 273, Issue 1, 2016, Pages 180-193

  El Benna, Jamel ^a,b   Hurtado Nedelec, Margarita ^a,b,c   Marzaioli, Viviana ^a,b   Marie, Jean Claude ^a,b,c   Gougerot Pocidalo, Marie Anne ^a,b,c   Dang, Pham My Chan ^a,b  

^a CENTRE DE RECHERCHE SUR L INFLAMMATION   (France)

^b Laboratoire d Excellence CORAIL   (France)

^c BICHAT HOSPITAL   (France)

Author keywords

NADPH oxidase NOX2; neutrophils; priming; superoxide ROS production

Indexed keywords

CHEMOATTRACTANT; PEPTIDYLPROLYL ISOMERASE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE;

CELL MIGRATION; CELL VACUOLE; ENZYME PHOSPHORYLATION; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; IN VITRO STUDY; INFLAMMATION; INFLAMMATORY DISEASE; LEUKOCYTE ADHERENCE; LEUKOCYTE ROLLING; MEDIATOR RELEASE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY BURST; REVIEW; VASCULAR ENDOTHELIUM;

EID: 84983490033     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12447     Document Type: Review

References (159)

1. Summers C, Rankin SM, Condliffe AM, Singh N, Peters AM, Chilvers ER. Neutrophil kinetics in health and disease. Trends Immunol 2010;31:318–324.
2. Caielli S, Banchereau J, Pascual V. Neutrophils come of age in chronic inflammation. Curr Opin Immunol 2012;24:671–677.
3. Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 2011;11:519–531.
4. Nauseef WM, Borregaard N. Neutrophils at work. Nat Immunol 2014;15:602–611.
5. Mócsai A. Diverse novel functions of neutrophils in immunity, inflammation, and beyond. J Exp Med 2013;210:1283–1299.
6. Kannengiesser C, et al. Molecular epidemiology of chronic granulomatous disease in a series of 80 kindreds: identification of 31 novel mutations. Hum Mutat 2008;29:E132–E149.
7. van de Vijver E, et al. Hematologically important mutations: leukocyte adhesion deficiency (firstupdate). Blood Cells Mol Dis 2012;48:53–61.
8. Segel GB, Halterman MW, Lichtman MA. The paradox of the neutrophil’s role in tissue injury. J Leukoc Biol 2011;89:359–372.
9. Wculek SK, Malanchi I. Neutrophils support lung colonization of metastasis-initiating breast cancer cells. Nature 2015;528:413–417.
10. Jönsson F, et al. Mouse and human neutrophils induce anaphylaxis. J Clin Invest 2011;121:1484–1496.
11. Battaglia M. Neutrophils and type 1 autoimmune diabetes. Curr Opin Hematol 2014;21:8–15.
12. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000;80:617–653.
13. Rabiet MJ, Huet E, Boulay F. The N-formyl peptide receptors and the anaphylatoxin C5a receptors: an overview. Biochimie 2007;89:1089–1106.
14. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007;7:678–689.
15. Soehnlein O, Lindbom L, Weber C. Mechanisms underlying neutrophil-mediated monocyte recruitment. Blood 2009;114:4613–4623.
16. Prince LR, Whyte MK, Sabroe I, Parker LC. The role of TLRs in neutrophil activation. Curr Opin Pharmacol 2011;11:397–403.
17. Hayashi F, Means TK, Luster AD. Toll-like receptors stimulate human neutrophil function. Blood 2003;102:2660–2669.
18. Hampton MB, Kettle AJ, Winterbourn CC. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 1998;12:3007–3017.
19. Nauseef WM. How human neutrophils kill and degrade microbes: an integrated view. Immunol Rev 2007;219:88–102.
20. Babior BM. Phagocytes and oxidative stress. Am J Med 2000;109:33–44.
21. El-Benna J, Dang PM, Gougerot-Pocidalo MA, Elbim C. Phagocyte NADPH oxidase: a multicomponent enzyme essential for host defenses. Arch Immunol Ther Exp (Warsz) 2005;53:199–206.
22. Babior BM. NADPH Oxidase: an update. Blood 1999;93:1464–1476.
23. Chanock SJ, El-Benna J, Smith RM, Babior BM. The respiratory burst oxidase. J Biol Chem 1994;269:24519–24522.
24. Groemping Y, Rittinger K. Activation and assembly of the NADPH oxidase: a structural perspective. Biochem J 2005;386:401–416.
25. Hallett MB, Lloyds DL. Neutrophil priming: the cellular signals that say ‘amber’ but not ‘green’. Immunol Today 1995;16:264–268.
26. El-Benna J, Dang PM, Gougerot-Pocidalo MA. Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane. Semin Immunopathol 2008;30:279–289.
27. Hurtado-Nedelec M, Makni-Maalej K, Gougerot-Pocidalo MA, Dang PM, El-Benna J. Assessment of priming of the human neutrophil respiratory burst. Methods Mol Biol 2014;1124:405–412.
28. Nauseef WM. Identification and quantitation of superoxide anion: essential steps in elucidation of the phagocyte “respiratory burst”. J Immunol 2014;193:5357–5358.
29. Dahlgren C, Karlsson A. Respiratory burst in human neutrophils. J Immunol Methods 1999;232:3–14.
30. Haslett C, Guthrie LA, Kopaniak MM, Johnston RB Jr, Henson PM. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 1985;119:101–110.
31. Stie J, Jesaitis AJ. Preparation of secretory vesicle-free plasma membranes by isopycnic sucrose gradient fractionation of neutrophils purified by the gelatin method. Cytotechnology 2004;46:109–122.
32. Yaffe MB, Xu J, Burke PA, Forse RA, Brown GE. Priming of the neutrophil respiratory burst is species-dependent and involves MAP kinase activation. Surgery 1999;126:248–254.
33. Mossmann H, Bamberger U, Velev BA, Gehrung M, Hammer DK. Effect of platelet-activating factor on human polymorphonuclear leukocyte enhancement of chemiluminescence and antibody-dependent cellular cytotoxicity. PAF Mossmann. J Leukoc Biol 1986;39:153–165.
34. Brown GE, Stewart M, Bissonnette SA, Elia AE, Wilker E, Yaffe MB. Distinct ligand-dependent roles for p38 MAPK in priming and activation of the neutrophil NADPH oxidase. J Biol Chem 2004;279:27059–27068.
35. Kitchen E, Rossi AG, Condliffe AM, Haslett C, Chilvers ER. Demonstration of reversible priming of human neutrophils using platelet-activating factor. Blood 1996;88:4330–4337.
36. McPhail LC, Clayton CC, Snyderman R. The NADPH oxidase of human polymorphonuclear leukocytes. Evidence for regulation by multiple signals. J Biol Chem 1984;259:5768–5775.
37. Daniels RH, Elmore MA, Hill ME, Shimizu Y, Lackie JM, Finnen MJ. Priming of the oxidative burst in human neutrophils by physiological agonists or cytochalasin B results from the recruitment of previously non-responsive cells. Immunology 1994;82:465–772.
38. Walker BAM, Ward PA. Priming and signal transduction in neutrophils. Biol Signals 1992;1:237–249.
39. Khwaja A, Carver JE, Linch DC. Interactions of granulocyte-macrophage colony-stimulating factor (CSF), granulocyte CSF, and tumor necrosis factor a in the priming of the neutrophil respiratory burst. Blood 1992;79:745–753.
40. Elbim C, Bailly S, Chollet-Martin S, Hakim J, Gougerot-Pocidalo M-A. Differential priming effects of proinflammatory cytokines on human neutrophil oxidative burst in response to bacterial N-formyl peptides. Infect Immun 1994;62:2195–2201.
41. McColl SR, Beauseigle D, Gilbert C, Naccache PH. Priming of the human neutrophil respiratory burst by granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha involves regulation at a post-cell surface receptor level. Enhancement of the effect of agents which directly activate G proteins. J Immunol 1990;145:3047–3053.
42. Dewas C, Dang PMC, Gougerot-Pocidalo M-A, El Benna J. TNF induces phosphorylation of p47phox in human neutrophils: partial phosphorylation of p47phox is a common event of priming of human neutrophils by TNF and granulocyte-macrophage colony-stimulating factor. J Immunol 2003;171:4392–4398.
43. Dang M-PC, Dewas C, Gaudry M, Fay M, Gougerot-Pocidalo MA, El Benna J. Priming of human neutrophil respiratory burst by granulocyte/macrophage colony-stimulating factor (GM-CSF) involves partial phosphorylation of p47phox. J Biol Chem 1999;274:20704–20708.
44. Elbim C, et al. Interleukin-18 primes the oxidative burst of neutrophils in response to formyl-peptides: role of cytochrome b558 translocation and N-formyl peptide receptor endocytosis. Clin Diagn Lab Immunol 2005;12:436–446.
45. Chedid P, et al. Adiponectin and its globular fragment differentially modulate the oxidative burst of primary human phagocytes. Am J Pathol 2012;180:682–692.
46. Forehand JR, Pabst MJ, Phillips WA, Johnston RB Jr. Lipopolysaccharide priming of human neutrophils for an enhanced respirator burst. Role of intracellular free calcium. J Clin Invest 1989;83:74–83.
47. DeLeo FR, et al. Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly. J Clin Invest 1998;101:455–463.
48. Almkvist J, Fäldt J, Dahlgren C, Leffler H, Karlsson A. Lipopolysaccharide-induced gelatinase granule mobilization primes neutrophils for activation by galectin-3 and formylmethionyl-Leu-Phe. Infect Immun 2001;69:832–837.
49. Hughes JE, Stewart J, Barclay GR, Govan JR. Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia. Infect Immun 1997;65:4281–4287.
50. Poltorak A, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282:2085–2088.
51. Makni-Maalej K, Boussetta T, Hurtado-Nedelec M, Belambri SA, Gougerot-Pocidalo MA, El-Benna J. The TLR7/8 agonist CL097 primes N-formyl-methionyl-leucyl-phenylalanine-stimulated NADPH oxidase activation in human neutrophils: critical role of p47phox phosphorylation and the proline isomerase Pin1. J Immunol 2012;189:4657–4665.
52. Makni-Maalej K, et al. TLR8, but not TLR7, induces the priming of the NADPH oxidase activation in human neutrophils. J Leukoc Biol 2015;97:1081–1087.
53. Kurt-Jones EA, et al. Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood 2002;100:1860–1868.
54. Lowell CA, Fumagalli L, Berton G. Deficiency of Src family kinases p59/61hck and p58c-fgr results in defective adhesion-dependent neutrophil functions. J Cell Biol 1996;133:895–910.
55. Ginis I, Tauber AI. Activation mechanisms of adherent human neutrophils. Blood 1990;76:1233–1239.
56. Liles WC, Ledbetter JA, Waltersdorph AW, Klebanoff SJ. Cross-linking of CD18 primes human neutrophils for activation of the respiratory burst in response to specific stimuli: implications for adhesion-dependent physiological responses in neutrophils. J Leukoc Biol 1995;58:690–697.
57. Zhou MJ, Brown EJ. CR3 (Mac-1, alpha M beta 2, CD11b/CD18) and Fc gamma RIII cooperate in generation of a neutrophil respiratory burst: requirement for Fc gamma RIII and tyrosine phosphorylation. J Cell Biol 1994;125:1407–1416.
58. Nathan C, et al. Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins. J Cell Biol 1989;109:1341–1349.
59. Keil ML, et al. Priming-induced localization of G(ialpha2) in high density membrane microdomains. Biochem Biophys Res Commun 2003;301:862–872.
60. Bauldry SA, McCall CE, Cousart SL, Bass DA. Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming. J Immunol 1991;146:1277–1285.
61. Nahas N, Waterman WH. Sha’afi RI. Granulocyte-macrophage colony-stimulating factor (GM-CSF) promotes phosphorylation and an increase in the activity of cytosolic phospholipase A2 in human neutrophils. Biochem J 1996;313:503–508.
62. Corey S, et al. Granulocyte macrophage-colony stimulating factor stimulates both association and activation of phosphoinositide 3OH-kinase and src-related tyrosine kinase(s) in human myeloid derived cells. EMBO J 1993;12:2681–2690.
63. Knall C, Worthen GS, Johnson GL. Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases. Proc Natl Acad Sci U S A 1997;94:3052–3057.
64. Cadwallader KA, et al. Regulation of phosphatidylinositol 3-kinase activity and phosphatidylinositol 3,4,5-trisphosphate accumulation by neutrophil priming agents. J Immunol 2002;169:3336–3344.
65. Bourgoin S, Plante E, Gaudry M, Naccache PH, Borgeat P, Poubelle PE. Involvement of a phospholipase D in the mechanism of action of granulocyte-macrophage colony-stimulating factor (GM-CSF): priming of human neutrophils in vitro with GM-CSF is associated with accumulation of phosphatidic acid and diradylglycerol. J Exp Med 1990;172:767–777.
66. Kodama T, Hazeki K, Hazeki O, Okada T, Ui M. Enhancement of chemotactic peptide-induced activation of phosphoinositide 3-kinase by granulocyte-macrophage colony-stimulating factor and its relation to the cytokine-mediated priming of neutrophil superoxide-anion production. Biochem J 1999;337:201–209.
67. Bauldry SA, Bass DA, Cousart SL, McCall CE. Tumor necrosis factor alpha priming of phospholipase D in human neutrophils. Correlation between phosphatidic acid production and superoxide generation. J Biol Chem 1991;266:4173–4179.
68. Nahas N, Molski TF, Fernandez GA, Sha’afi RI. Tyrosine phosphorylation and activation of a new mitogen-activated protein (MAP)-kinase cascade in human neutrophils stimulated with various agonists. Biochem J 1996;318:247–253.
69. McLeish KR, et al. Activation of mitogen-activated protein kinase cascades during priming of human neutrophils by TNF-alpha and GM-CSF. J Leukoc Biol 1998;64:537–545.
70. Iyer SS, Pearson DW, Nauseef WM, Clark RA. Evidence for a readily dissociable complex of p47phox and p67phox in cytosol of unstimulated human neutrophils. J Biol Chem 1994;269:22405–22411.
71. Park JW, Benna JE, Scott KE, Christensen BL, Chanock SJ, Babior BM. Isolation of a complex of respiratory burst oxidase components from resting neutrophil cytosol. Biochemistry 1994;33:2907–2911.
72. Lapouge K, Smith SJ, Groemping Y, Rittinger K. Architecture of the p40-p47-p67phox complex in the resting state of the NADPH oxidase. A central role for p67phox. J Biol Chem 2002;277:10121–10128.
73. Groemping Y, Lapouge K, Smerdon SJ, Rittinger K. Molecular basis of phosphorylation-induced activation of the NADPH oxidase. Cell 2003;113:343–355.
74. Abo A, Webb MR, Grogan A, Segal AW. Activation of NADPH oxidase involves the dissociation of p21rac from its inhibitory GDP/GTP exchange protein (rhoGDI) followed by its translocation to the plasma membrane. Biochem J 1994;298:585–591.
75. Borregaard N, Heiple JM, Simons ER, Clark RA. Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation. J Cell Biol 1983;97:52–61.
76. Sheppard FR, Kelher MR, Moore EE, McLaughlin NJ, Banerjee A, Silliman CC. Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation. J Leukoc Biol 2005;78:1025–1042.
77. Ward RA, Nakamura M, McLeish KR. Priming of the neutrophil respiratory burst involves p38 mitogen-activated protein kinase-dependent exocytosis of flavocytochrome b558-containing granules. J Biol Chem 2000;275:36713–36719.
78. Fäldt J, Dahlgren C, Ridell M, Karlsson A. Priming of human neutrophils by mycobacterial lipoarabinomannans: role of granule mobilization. Microbes Infect 2001;3:1101–1109.
79. Mansfield PJ, Hinkovska-Galcheva V, Shayman JA, Boxer LA. Granulocyte colony-stimulating factor primes NADPH oxidase in neutrophils through translocation of cytochrome b(558) by gelatinase-granule release. J Lab Clin Med 2002;140:9–16.
80. Uriarte SM, et al. Granule exocytosis contributes to priming and activation of the human neutrophil respiratory burst. J Immunol 2011;187:391–400.
81. Bai J, et al. TAT-SNAP-23 treatment inhibits the priming of neutrophil functions contributing to shock and/or sepsis-induced extra-pulmonary acute lung injury. Innate Immun 2015;21:42–54.
82. El Benna J, Faust LP, Babior BM. The phosphorylation of the respiratory burst oxidase component p47phox during neutrophil activation. Phosphorylation of sites recognized by protein kinase C and by proline-directed kinases. J Biol Chem 1994;269:23431–23436.
83. El-Benna J, Dang PM, Gougerot-Pocidalo MA, Marie JC, Braut-Boucher F. p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases. Exp Mol Med 2009;41:217–225.
84. Dang PMC, et al. A specific p47phox -serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites. J Clin Invest 2006;116:2033–2043.
85. Hurtado-Nedelec M, et al. Increased reactive oxygen species production and p47phox phosphorylation in neutrophils from myeloproliferative disorders patients with JAK2 (V617F) mutation. Haematologica 2013;98:1517–1524.
86. El-Benna J, et al. Phosphorylation of the respiratory burst oxidase subunit p67(phox) during human neutrophil activation. Regulation by protein kinase C-dependent and independent pathways. J Biol Chem 1997;272:17204–17208.
87. Forbes LV, Truong O, Wientjes FB, Moss SJ, Segal AW. The major phosphorylation site of the NADPH oxidase component p67phox is Thr233. Biochem J 1999;338:99–105.
88. Dang PMC, et al. The NADPH oxidase cytosolic component p67phox is constitutively phosphorylated in human neutrophils: regulation by a protein tyrosine kinase, MEK1/2 and phosphatases 1/2A. Biochem Pharmacol 2011;82:1145–1152.
89. Dang PM, Morel F, Gougerot-Pocidalo MA, Benna JE. Phosphorylation of the NADPH oxidase component p67(PHOX) by ERK2 and P38MAPK: selectivity of phosphorylated sites and existence of an intramolecular regulatory domain in the tetratricopeptide-rich region. Biochemistry 2003;42:4520–4526.
90. Bouin AP, Grandvaux N, Vignais PV, Fuchs A. p40(phox) is phosphorylated on threonine 154 and serine 315 during activation of the phagocyte NADPH oxidase. Implication of a protein kinase C-type kinase in the phosphorylation process. J Biol Chem 1998;273:30097–30103.
91. Regier DS, Greene DG, Sergeant S, Jesaitis AJ, McPhail LC. Phosphorylation of p22phox is mediated by phospholipase D-dependent and -independent mechanisms. Correlation of NADPH oxidase activity and p22phox phosphorylation. J Biol Chem 2000;275:28406–28412.
92. Raad H, et al. Regulation of the phagocyte NADPH oxidase activity: phosphorylation of gp91phox/NOX2 by protein kinase C enhances its diaphorase activity and binding to Rac2, p67phox, and p47phox. FASEB J 2009;23:1011–1022.
93. Lewis EM, Sergeant S, Ledford B, Stull N, Dinauer MC, McPhail LC. Phosphorylation of p22phox on threonine 147 enhances NADPH oxidase activity by promoting p47phox binding. J Biol Chem 2010;285:2959–2967.
94. Park JW, Babior BM. Activation of the leukocyte NADPH oxidase subunit p47phox by protein kinase C. A phosphorylation-dependent change in the conformation of the C-terminal end of p47phox. Biochemistry 1997;36:7474–7480.
95. Swain SD, Helgerson SL, Davis AR, Nelson LK, Quinn MT. Analysis of activation-induced conformational changes in p47phox using tryptophan fluorescence spectroscopy. J Biol Chem 1997;272:29502–29509.
96. Marcoux J, Man P, Castellan M, Vivès C, Forest E, Fieschi F. Conformational changes in p47(phox) upon activation highlighted by mass spectrometry coupled to hydrogen/deuterium exchange and limited proteolysis. FEBS Lett 2009;583:835–840.
97. Sumimoto H, et al. Role of Src homology 3 domains in assembly and activation of the phagocyte NADPH oxidase. Proc Natl Acad Sci USA 1994;91:5345–5349.
98. de Mendez I, Homayounpour N, Leto TL. Specificity of p47phox SH3 domain interactions in NADPH oxidase assembly and activation. Mol Cell Biol 1997;17:2177–2185.
99. Shiose A, Sumimoto H. Arachidonic acid and phosphorylation synergistically induce a conformational change of p47phox to activate the phagocyte NADPH oxidase. J Biol Chem 2000;275:13793–13801.
100. Dang PMC, Cross AR, Quinn MT, Babior BM. Assembly of the neutrophil respiratory burst oxidase: a direct interaction between p67PHOX and cytochrome b558 II. Proc Natl Acad Sci USA 2002;99:4262–4265.
101. Boussetta T, et al. The prolyl isomerase Pin1 acts as a novel molecular switch for TNF-alpha-induced priming of the NADPH oxidase in human neutrophils. Blood 2010;116:5795–5802.
102. Yaffe MB, et al. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 1997;278:1957–1960.
103. Liou YC, Zhou XZ, Lu KP. Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins. Trends Biochem Sci 2011;36:501–514.
104. Durand D, et al. NADPH oxidase activator p67(phox) behaves in solution as a multidomain protein with semi-flexible linkers. J Struct Biol 2010;169:45–53.
105. Taylor RM, Riesselman MH, Lord CI, Gripentrog JM, Jesaitis AJ. Anionic lipid-induced conformational changes in human phagocyte flavocytochrome b precede assembly and activation of the NADPH oxidase complex. Arch Biochem Biophys 2012;521:24–31.
106. Berthier S, et al. Changing the conformation state of cytochrome b558 initiates NADPH oxidase activation: MRP8/MRP14 regulation. J Biol Chem 2003;278:25499–25508.
107. Paclet MH, Berthier S, Kuhn L, Garin J, Morel F. Regulation of phagocyte NADPH oxidase activity: identification of two cytochrome b558 activation states. FASEB J 2007;21:1244–1255.
108. Hashida S, et al. Binding of FAD to cytochrome b558 is facilitated during activation of the phagocyte NADPH oxidase, leading to superoxide production. J Biol Chem 2004;279:26378–26386.
109. Campion Y, et al. New insights into the membrane topology of the phagocyte NADPH oxidase: characterization of an anti-gp91-phox conformational monoclonal antibody. Biochimie 2007;89:1145–1158.
110. Ferrante A, et al. Killing of Staphylococcus aureus by tumor necrosis factor-alpha-activated neutrophils. The role of serum opsonins, integrin receptors, respiratory burst, and degranulation. J Immunol 1993;151:4821–4828.
111. Ferrante A. Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release. Infect Immun 1989;57:2115–2122.
112. Rainard P, Riollet C, Poutrel B, Paape MJ. Phagocytosis and killing of Staphylococcus aureus by bovine neutrophils after priming by tumor necrosis factor-alpha and the des-arginine derivative of C5a. Am J Vet Res 2000;61:951–959.
113. Mayer P, Lam C, Obenaus H, Liehl E, Besemer J. Recombinant human GM-CSF induces leukocytosis and activates peripheral blood polymorphonuclear neutrophils in nonhuman primates. Blood 1987;70:206–213.
114. Jennings RT, et al. RhoA determines disease progression by controlling neutrophil motility and restricting hyperresponsiveness. Blood 2014;123:3635–3645.
115. Wewers MD, et al. Tumor necrosis factor infusions in humans prime neutrophils for hypochlorous acid production. Am J Physiol 1990;259:L276–L282.
116. Baldwin GC, et al. Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients. Proc Natl Acad Sci USA 1988;85:2763–2766.
117. Karlsson A, Markfjäll M, Strömberg N, Dahlgren C. Escherichia coli-induced activation of neutrophil NADPH-oxidase: lipopolysaccharide and formylated peptides act synergistically to induce release of reactive oxygen metabolites. Infect Immun 1995;63:4606–4612.
118. Pillay J, et al. Functional heterogeneity and differential priming of circulating neutrophils in human experimental endotoxemia. J Leukoc Biol 2010;88:211–220.
119. van Bruggen R, et al. Complement receptor 3 and Toll-like receptor 4 act sequentially in uptake and intracellular killing of unopsonized Salmonella enterica serovar Typhimurium by human neutrophils. Infect Immun 2007;75:2655–2660.
120. Bass DA, Olbrantz P, Szejda P, Seeds MC, McCall CE. Subpopulations of neutrophils with increased oxidative product formation in blood of patients with infection. J Immunol 1986;136:860–866.
121. Elbim C, et al. Defective priming of the phagocyte oxidative burst in a child with recurrent intracellular infections. Microbes Infect 1999;1:581–587.
122. Picard C, et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 2003;299:2076–2079.
123. Singh A, Zarember KA, Kuhns DB, Gallin JI. Impaired priming and activation of the neutrophil NADPH oxidase in patients with IRAK4 or NEMO deficiency. J Immunol 2009;182:6410–6417.
124. Condliffe AM, Kitchen E, Chilvers ER. Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin Sci (Lond) 1998;94:461–471.
125. Sellak H, Franzini E, Hakim J, Pasquier C. Reactive oxygen species rapidly increase endothelial ICAM-1 ability to bind neutrophils without detectable upregulation. Blood 1994;83:2669–2677.
126. Zhu L, He P. fMLP-stimulated release of reactive oxygen species from adherent leukocytes increases microvessel permeability. Am J Physiol Heart Circ Physiol 2006;290:H365–H372.
127. Wyman TH, et al. A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release. Am J Physiol Cell Physiol 2002;283:C1592–C1603.
128. Jacobi J, Sela S, Cohen HI, Chezar J, Kristal B. Priming of polymorphonuclear leukocytes: a culprit in the initiation of endothelial cell injury. Am J Physiol Heart Circ Physiol 2006;290:H2051–H2058.
129. Lauterbach M, O’Donnell P, Asano K, Mayadas TN. Role of TNF priming and adhesion molecules in neutrophil recruitment to intravascular immune complexes. J Leukoc Biol 2008;83:1423–1430.
130. Guice KS, Oldham KT, Caty MG, Johnson KJ, Ward PA. Neutrophil-dependent, oxygen-radical mediated lung injury associated with acute pancreatitis. Ann Surg 1989;210:740–747.
131. Conner WC, Gallagher CM, Miner TJ, Tavaf-Motamen H, Wolcott KM, Shea-Donohue T. Neutrophil priming state predicts capillary leak after gut ischemia in rats. J Surg Res 1999;84:24–30.
132. Sela S, et al. Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. J Am Soc Nephrol 2005;16:2431–2438.
133. Erratum in: J Am Soc Nephrol 2005,16:2814-2822
134. Choi JC, et al. Granulocyte macrophage-colony stimulating factor (GM-CSF) augments acute lung injury via its neutrophil priming effects. J Korean Med Sci 2008;23:288–295.
135. Qian F, et al. A non-redundant role for MKP5 in limiting ROS production and preventing LPS-induced vascular injury. EMBO J 2009;28:2896–2907.
136. Worthen GS, Haslett C, Rees AJ, Gumbay RS, Henson JE, Henson PM. Neutrophil-mediated pulmonary vascular injury. Synergistic effect of trace amounts of lipopolysaccharide and neutrophil stimuli on vascular permeability and neutrophil sequestration in the lung. Am Rev Respir Dis 1987;136:19–28.
137. Metnitz PG, Bartens C, Fischer M, Fridrich P, Steltzer H, Druml W. Antioxidant status in patients with acute respiratory distress syndrome. Intensive Care Med 1999;25:180–185.
138. Chollet-Martin S, et al. Subpopulation of hyperresponsive polymorphonuclear neutrophils in patients with adult respiratory distress syndrome. Role of cytokine production. Am Rev Respir Dis 1992;146:990–996.
139. Firestein GS, Zvaifler NJ. Rheumatoid Arthritis: a disease of disordered immunity. In: Gallin JI, Goldstein IM, Snyderman R eds. Inflammation. Basic Principles and Clinical Correlates. 2nd edn. New York: Raven Press, 1992:959–977.
140. Arnett FC, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–324.
141. 2 system by synovial fluid isolated from patients with rheumatoid arthritis. Ann Rheum Dis 1991;50:237–242.
142. Nurcombe HL, Bucknall RC, Edwards SW. Neutrophils isolated from the synovial fluid of patients with rheumatoid arthritis: priming and activation in vivo. Ann Rheum Dis 1991;50:147–153.
143. El Benna J, et al. Polymorphonuclear neutrophil NADPH oxidase priming and p47phox phosphorylation in rheumatoid joints. Inflamm 2002;26:273–278.
144. Keane KN, Cruzat VF, Carlessi R, de Bittencourt PI, Newsholme P Jr. Molecular events linking oxidative stress and inflammation to insulin resistance and β-cell dysfunction. Oxid Med Cell Longev 2015;2015:181643.
145. Shurtz-Swirski R, et al. Involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetic patients. Diabetes Care 2001;24:104–110.
146. Karima M, et al. Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis. J Leukoc Biol 2005;78:862–870.
147. Omori K, et al. Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase. J Leukoc Biol 2008;84:292–301.
148. Lawson S, Ward DT, Conner C, Gallagher C, Tsokos G, Shea-Donohue T. Diabetic hyperglycemia: a facilitating factor in systemic capillary leak. J Surg Res 2002;105:95–101.
149. Mazor R, et al. Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients. Atherosclerosis 2008;197:937–943.
150. Wong RK, Pettit AI, Davies JE, Ng LL. Augmentation of the neutrophil respiratory burst through the action of advanced glycation end products: a potential contributor to vascular oxidant stress. Diabetes 2002;51:2846–2853.
151. James C, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005;434:1144–1148.
152. Iki S, et al. Increased neutrophil respiratory burst in myeloproliferative disorders: selective enhancement of superoxide release triggered by receptor-mediated agonists and low responsiveness to in vitro cytokine stimulation. Exp Hematol 1997;25:26–33.
153. Edashige K, Watanabe Y, Sato EF, Takehara Y, Utsumi K. Reversible priming and protein-tyrosyl phosphorylation in human peripheral neutrophils under hypotonic conditions. Arch Biochem Biophys 1993;302:343–347.
154. Brown GE, Reiff J, Allen RC, Silver GM, Fink MP. Maintenance and down-regulation of primed neutrophil chemiluminescence activity in human whole blood. J Leukoc Biol 1997;62:837–844.
155. Summers C, et al. Pulmonary retention of primed neutrophils: a novel protective host response, which is impaired in the acute respiratory distress syndrome. Thorax 2014;69:623–629.
156. Singh NR, Johnson A, Peters AM, Babar J, Chilvers ER, Summers C. Acute lung injury results from failure of neutrophil de-priming: a new hypothesis. Eur J Clin Invest 2012;42:1342–1349.
157. Laichalk LL, Danforth JM, Standiford TJ. Interleukin-10 inhibits neutrophil phagocytic and bactericidal activity. FEMS Immunol Med Microbiol 1996;15:181–187.
158. Roilides E, Katsifa H, Tsaparidou S, Stergiopoulou T, Panteliadis C, Walsh TJ. Interleukin 10 suppresses phagocytic and antihyphal activities of human neutrophils. Cytokine 2000;12:379–387.
159. Dang PM, Elbim C, Marie JC, Chiandotto M, Gougerot-Pocidalo MA, El-Benna J. Anti-inflammatory effect of interleukin-10 on human neutrophil respiratory burst involves inhibition of GM-CSF-induced p47PHOX phosphorylation through a decrease in ERK1/2 activity. FASEB J 2006;20:1504–1506.